DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
24 Nov 2023
Historique:
accepted: 07 11 2023
revised: 29 10 2023
received: 28 07 2023
medline: 25 11 2023
pubmed: 25 11 2023
entrez: 24 11 2023
Statut: aheadofprint

Résumé

Although ubiquitylation had traditionally been considered limited to proteins, the discovery of non-proteinaceous substrates (e.g. lipopolysaccharides and adenosine diphosphate ribose (ADPr)) challenged this perspective. Our recent study showed that DTX2 E3 ligase efficiently ubiquitylates ADPr. Here, we show that the ADPr ubiquitylation activity is also present in another DELTEX family member, DTX3L, analysed both as an isolated catalytic fragment and the full-length PARP9:DTX3L complex, suggesting that it is a general feature of the DELTEX family. Since structural predictions show that DTX3L possesses single-stranded nucleic acids binding ability and given the fact that nucleic acids have recently emerged as substrates for ADP-ribosylation, we asked whether DELTEX E3s might catalyse ubiquitylation of an ADPr moiety linked to nucleic acids. Indeed, we show that DTX3L and DTX2 are capable of ubiquitylating ADP-ribosylated DNA and RNA synthesized by PARPs, including PARP14. Furthermore, we demonstrate that the Ub-ADPr-nucleic acids conjugate can be reversed by two groups of hydrolases, which remove either the whole adduct (e.g. SARS-CoV-2 Mac1 or PARP14 macrodomain 1) or just the Ub (e.g. SARS-CoV-2 PLpro). Overall, this study reveals ADPr ubiquitylation as a general function of the DELTEX family E3s and presents the evidence of reversible ubiquitylation of ADP-ribosylated nucleic acids.

Identifiants

pubmed: 38000390
pii: 7449489
doi: 10.1093/nar/gkad1119
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007195/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Auteurs

Kang Zhu (K)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Marcin J Suskiewicz (MJ)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Orléans, France.

Chatrin Chatrin (C)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Øyvind Strømland (Ø)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Department of Biomedicine, University of Bergen, Bergen, Norway.

Bryan W Dorsey (BW)

Ribon Therapeutics, 35 Cambridgepark Dr., Suite 300, Cambridge MA 02140, USA.

Vincent Aucagne (V)

Centre de Biophysique Moléculaire, CNRS UPR 4301, Orléans, France.

Dragana Ahel (D)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Ivan Ahel (I)

Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

Classifications MeSH